Business
Teva and Regeneron announce global collaboration to develop Fasinumab; Will share equally in revenue and R&D costs of $1 billion for the osteoarthritis and...
Hi, what are you looking for?
Jewish Business News
Business
"Slowing down the progression of this disease has proven to be impossible until now, " said Teva VP Spyros Papapetropoulos:
Business
The Israeli company is developing a proprietary oral insulin for intestinal malabsorption in preterm newborns and Short Bowel Syndrome in infants.
Business
The Israeli pharmaceutical company is paying $33.43 billion in cash and $5.3 billion in shares.
Business
Anda is the fourth largest distributor of generic pharmaceuticals in the US.
Business
Breakthrough Israeli cancer treatment drug was approved in record time by the UK. BBC's report leaves out the "made in Israel" part.
Life science
500 China-Israel B2B meetings held during 15th annual Israel Biomed Conference.
Business
The financing will be used to fund a multi-center Phase IIb clinical trial for Acute Myeloid Leukemia (AML) drug Astarabine.
Business
Senate lawmakers investigating price hikes by the embattled drugmaker Valeant Pharmaceuticals will also question one of the company’s leading investors, hedge fund manager William...